India's Richest People 2026 edition · 1 director · Source: Hurun India
- #1,233 Arpit Janmejay Vyas ₹1,900 Cr
Revenue · FY 2025
₹27.14 Cr
▲ 237% YoY
Net profit · FY 2025
₹30 Lakh
Net margin 1.1%
EBITDA · FY 2025
₹5.73 Cr
EBITDA margin 21.1%
Authorised capital
₹6.5 Cr
Registered with MCA
Paid-up capital
₹6.5 Cr
Issued & subscribed
Open charges
₹163 Cr
Satisfied ₹128.41 Cr
Company age
31 yrs
Est. 1995
Employees · EPFO
17
Provident fund records
About Dishman Biotech Limited
Data last updated:
Dishman Biotech Limited is a public limited company based in Ahmedabad, Gujarat, India, a subsidiary of Dishman Carbogen Amcis Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 November 1995 and has been in existence for over 31 years.
Its director Arpit Janmejay Vyas is #1,233 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24231GJ1995PLC028060. Its GSTIN is 24AACCS0988C1ZJ (Gujarat).
The company has an authorised share capital of ₹6.5 Cr and a paid-up capital of ₹6.5 Cr. It was formerly known as Schutz Dishman Biotech Limited and Schutz Dishman Biotech Private Limited. It is led by directors including Deohooti Janmejay Vyas and Aditi Janmejay Vyas.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Dishman Corporate House Iscon – Bopal Road Ambli, Ahmedabad, Gujarat, India – 380058.
As per the financials filed for FY 2025, the company reported a revenue of ₹27.14 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹30 Lakh (net margin 1.1%) and EBITDA of ₹5.73 Cr (EBITDA margin 21.1%). Revenue has grown at a compounded annual rate (CAGR) of 49% over three years and 4% over five years.
The company has about 17 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹163 Cr and satisfied charges of ₹128.41 Cr on record. Court records list 16 cases involving the company, including 16 filed against it; 5 cases are pending. The company has 1 deal on record (1 acquisition); the latest was in March 2016. Its 10 peer companies in the Chemicals industry (Industrial Chemicals) are compared by revenue, 5 larger and 5 smaller; the largest is Thakar Dass & Co Private Limited with revenue of ₹27.23 Cr. The company has 3 MSME Form 1 returns on record between 2019 and 2020, listing 50 overdue payments to 20 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website dishmangroup.com.
Company Details of Dishman Biotech Limited
CIN U24231GJ1995PLC028060
Registration Number 028060
Incorporation Date 08 November 1995
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Dishman Carbogen Amcis Limited
Compliance Status Active Compliant
Name History of Dishman Biotech Limited
Dishman Biotech has undergone 2 name changes throughout its history. The company was previously known as Schutz Dishman Biotech Limited, and Schutz Dishman Biotech Private Limited. The current legal name is Dishman Biotech Limited.
| Company Name | Status |
|---|---|
| Dishman Biotech Limited | Current |
| Schutz Dishman Biotech Limited | Previous |
| Schutz Dishman Biotech Private Limited | Previous |
Key People
Deohooti Janmejay Vyas Director Aditi Janmejay Vyas Director Arpit Janmejay Vyas Director Recognitions & Rankings of Dishman Biotech
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressDishman Corporate House Iscon – Bopal Road Ambli, Ahmedabad, Gujarat, India – 380058
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Dishman Biotech Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Dishman Biotech Limited
The main business activity of Dishman Biotech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Dishman Biotech Limited FY 2025 filings available
Dishman Biotech Limited reported revenue of ₹27.14 Cr (up 237% YoY) for FY 2025.
Revenue · FY 2025
₹27.14 Cr ▲ 237%
Net profit · FY 2025
₹30 Lakh margin 1.1%
EBITDA · FY 2025
₹5.73 Cr margin 21.1%
Compounded Annual Growth Rate (CAGR) of Dishman Biotech Limited
Revenue CAGR growth
1 year
▲ 237%
3 years · compounded
▲ 49%
5 years · compounded
▲ 4%
EBITDA CAGR growth
1 year
▼ 23%
3 years · compounded
▼ 6%
5 years · compounded
▼ 11%
Revenue has grown at a compounded annual rate (CAGR) of 4% over five years, including 237% growth in the latest year. EBITDA fell 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Dishman Biotech Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹5.73 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹30 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Dishman Biotech Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 21.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Dishman Biotech are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Dishman Biotech Limited
Dishman Biotech has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deohooti Janmejay Vyas Also directs: Adimans Technologies LLP, Dishman Carbogen Amcis Limited, B R Laboratories Limited and 5 more | Director | 01 Dec 1997 | 28 Years 10 Months | Current |
| Aditi Janmejay Vyas Also directs: B R Laboratories Limited, Azafran Innovacion Limited, Dishman Infrastructure Limited and 3 more | Director | 01 Dec 1997 | 28 Years 10 Months | Current |
| Arpit Janmejay Vyas Also directs: Dishman Carbogen Amcis Limited, RTV Technochem Private Limited, Leon Hospitality Private Limited and 5 more | Director | 03 Jun 2009 | 17 Years 4 Months | Current |
Peer Comparison of Dishman Biotech Limited
Dishman Biotech Limited is compared with the companies closest to it by revenue in the Chemicals industry (Industrial Chemicals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Thakar Dass & Co Private Limited | ₹27.23 Cr (FY 2024) | •••• | •••• | 24.0% | •••• | New Delhi, Delhi, India |
| Dhanera Texchem Private Limited | ₹27.23 Cr (FY 2024) | •••• | •••• | -31.0% | •••• | Vanijya Bhavan, Kankariya, Gujarat, India |
| Vismita Intermediates Private Limited | ₹27.18 Cr (FY 2025) | •••• | •••• | 26.0% | •••• | Ankleshwar, Gujarat, India |
| Hind Suter Shellac Private Limited | ₹27.17 Cr (FY 2024) | •••• | •••• | -37.0% | •••• | Howrah, West Bengal, India |
| Vtar Private Limited | ₹27.14 Cr (FY 2025) | •••• | •••• | 96.0% | •••• | Vadodara, Gujarat, India |
| Dishman Biotech Limited this company | ₹27.14 Cr (FY 2025) | •••• | •••• | 237.0% | •••• | Ahmedabad, Gujarat, India |
| Bhabani Colors Private Limited | ₹27.09 Cr (FY 2025) | •••• | •••• | 18303.0% | •••• | Delhi, India |
| Maa Industrial Chemicals & Engineers Private Limited | ₹27.06 Cr (FY 2024) | •••• | •••• | 109.0% | •••• | Kolkata, West Bengal, India |
| Aastha Salt Marketing Private Limited | ₹26.98 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Kolkata, West Bengal, India |
| Savitri Global Exports Private Limited | ₹26.92 Cr (FY 2025) | •••• | •••• | 184.0% | •••• | Dabra, Madhya Pradesh, India |
| Kevy's Generics Private Limited | ₹26.72 Cr (FY 2024) | •••• | •••• | 9.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Dishman Biotech by revenue in the Chemicals industry (Industrial Chemicals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Dishman Biotech Limited
Dishman Biotech Limited is audited by Mukesh M. Shah & co. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Mukesh M. Shah & co. | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Dishman Biotech Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Dishman Biotech Limited
Open charges
₹163 Cr
Satisfied charges
₹128.41 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Sep 2025 | Others | ₹75 Cr | Open |
| 26 Aug 2025 | Others | ₹25 Cr | Open |
| 31 Jul 2025 | Others | ₹15 Cr | Open |
| 31 Dec 2024 | Others | ₹10 Cr | Open |
| 01 Apr 2024 | Others | ₹38 Cr | Open |
Total charge records: 10 View all charges
Deals & Funding of Dishman Biotech Limited
Dishman Biotech Limited has 1 deal on record (1 acquisition); the latest was in March 2016.
Total deals
1
Acquisition
1
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2016 | Acquisition | ₹2.26 Cr | Buyer: Dishman Pharmaceuticals and Chemicals Limited Seller: Schütz and Co. Beteiligungsgesellschaft mbH |
Premium access
Full deal history
All 1 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Dishman Biotech Limited
Dishman Biotech Limited has 16 court cases on record: 16 filed against it. 5 cases are pending and 11 are disposed. Status as checked between 01 Oct 2026 and 04 Oct 2026.
Total cases
16
Filed against the company
16
Pending
5
Disposed
11
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 16 | 16 | 5 |
Cases on record (5 of 16)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Gujarat | Court case (TAXAP) | Filed against the company by Principal Commissioner of Income Tax 4 | Pending |
| High Court of Gujarat | Court case (TAXAP) | Filed against the company by Pr.Commissioner of Income Tax-Iv | Pending |
| High Court of Gujarat | Court case (TAXAP) | Filed against the company by Principal Commissioner of Income Tax-1 | Disposed |
| High Court of Gujarat | Court case (TAXAP) | Filed against the company by Principal Commissioner of Income Tax 4 | Disposed |
| High Court of Gujarat | Court case (TAXAP) | Filed against the company by Commissioner of Income Tax(Tds) | Disposed |
Premium access
Full case history
All 16 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Dishman Biotech Limited
Dishman Biotech Limited has 3 MSME Form 1 returns on record between 2019 and 2020, listing 50 overdue payments to 20 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 20)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Vijay Transtech Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Target Sales | •••• | •••• | •••• |
| Novex Poly Films Private Limited | •••• | •••• | •••• |
| Sap Industries Limited | •••• | •••• | •••• |
Premium access
Full MSME payment history
Every supplier, amount and due date from all 3 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Dishman Biotech Limited
Dishman Biotech Limited has a workforce of 17 employees as of Apr 02, 2024.
Employee count
17
Active EPFO establishments
1
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Dishman Biotech Limited
Dishman Biotech Limited has 9 board changes on record since 1997: 3 appointments and 6 cessations. The latest: Janmejay Rajnikant Vyas ceased to be Director on 27 May 2025.
Charges
A charge registered on 18 Feb 2020 via Charge ID 100330460 with Others was fully satisfied on 12 Nov 2025.
Charges
A charge registered on 18 Feb 2020 via Charge ID 100332685 with Others was fully satisfied on 12 Nov 2025.
Charges
A charge registered on 18 Feb 2020 via Charge ID 100330429 with Others was fully satisfied on 12 Nov 2025.
AGM
Dishman Biotech Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 75.00 Cr with Charge ID 101165974 was registered on 30 Sep 2025.
Charges
A charge with Others amounted to Rs. 25.00 Cr with Charge ID 101147183 was registered on 26 Aug 2025.
Charges
A charge with Others amounted to Rs. 15.00 Cr with Charge ID 101150594 was registered on 31 Jul 2025.
Ceased
Janmejay Rajnikant Vyas ceased to be Director.
Filing
Dishman Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with Others amounted to Rs. 10.00 Cr with Charge ID 101047540 was registered on 31 Dec 2024.
Charges
A charge with Others amounted to Rs. 38.00 Cr with Charge ID 100915027 was registered on 01 Apr 2024.
Charges
A charge with Others of Rs. 40.73 Cr registered on 18 Feb 2020 with Charge ID 100330429 was modified on 15 Apr 2022.
18 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Dishman Biotech Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Dishman Biotech Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Dishman Biotech Limited
Dishman Biotech has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AACCS0988C1ZJ | Gujarat | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Dishman Biotech Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Related news about Dishman Biotech Limited
Frequently Asked Questions about Dishman Biotech Limited
Dishman Biotech is an active public limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 November 1995 (31+ years old) and is registered under CIN U24231GJ1995PLC028060.
Dishman Biotech reported revenue of ₹27.14 Cr for FY 2025 (up 237% YoY).
Dishman Biotech has 3 current directors:
- Deohooti Janmejay Vyas - Director
- Aditi Janmejay Vyas - Director
- Arpit Janmejay Vyas - Director
Dishman Biotech reported a net profit of ₹30 Lakh (net margin 1.1%) and EBITDA of ₹5.73 Cr (EBITDA margin 21.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Dishman Biotech is 49% over three years and 4% over five years. In the latest year (FY 2025) revenue rose 237%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Dishman Biotech is 24AACCS0988C1ZJ, registered in Gujarat.
The CIN (Corporate Identification Number) of Dishman Biotech is U24231GJ1995PLC028060. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dishman Biotech has 16 court cases on record: 16 filed against it. 5 are pending.
Dishman Biotech was incorporated on 08 November 1995, making it 31+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Dishman Biotech has 1 deal on record (1 acquisition); the latest was in March 2016.
The peers of Dishman Biotech by revenue are Thakar Dass & Co Private Limited, Dhanera Texchem Private Limited, Vismita Intermediates Private Limited, Hind Suter Shellac Private Limited, Vtar Private Limited and 5 more, all in the Chemicals industry (Industrial Chemicals).
Janmejay Rajnikant Vyas ceased to be Director on 27 May 2025. Katrin Adelheid Tiemann ceased to be Director on 01 Apr 2016. Reinhold Jakob Alt ceased to be Director on 01 Apr 2016. Dishman Biotech has 9 board changes on record in total.